Irinotecan in Treating Patients With Esophageal or Stomach Cancer

NCT00003748 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Cancer
Gastric Cancer

Interventions

DRUG: irinotecan hydrochloride

Sponsor

Jonsson Comprehensive Cancer Center

Collaborators

[object Object]